Tags: Allergies | ragwitek | ragweed | allergy | merck

Help For Ragweed Allergy

Thursday, 17 Apr 2014 04:02 PM

 

The U.S. Food and Drug Administration has approved Merck & Co's pollen allergy drug Ragwitek.

The tablet, which is administered by placing it under the tongue, is to treat the short ragweed pollen induced allergic rhinitis.

The approval for Ragwitek comes days after U.S. regulatory approval for Merck's grass pollen allergy drug Grastek.

Merck's Ragwitek will compete with Stallergenes SA's immunotherapy treatment for five types of grass pollen, which was approved by the FDA earlier this month.

© 2015 Thomson/Reuters. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Drug for Low Thyroid Condition

Tuesday, 27 Jan 2015 12:41 PM

A new drug has been approved to raise calcium levels in patients with low thyroid conditions. The U.S. Food and Drug Adm . . .

Combo Blood Pressure Medication

Tuesday, 27 Jan 2015 12:34 PM

A new combination pill to treat people with high blood pressure has won approval from the U.S. Food and Drug Administrat . . .

Generic Nexium Approved

Monday, 26 Jan 2015 16:24 PM

The U.S. Food and Drug Administration said it approved Teva Pharmaceutical's generic version of AstraZeneca's blockbuste . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved